GRTS
Gritstone Oncology Inc
NASDAQ: GRTS · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-30
Market cap
$3.80M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
—
Gritstone Oncology Inc (GRTS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,995.00%
ROE
-201.90%
ROA
-46.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-18.75M | — | — | — |
| 2017 | $0.00 | $-41.38M | — | — | — |
| 2018 | $1.19M | $-64.78M | 100.00% | -5,525.19% | -5,457.03% |
| 2019 | $4.37M | $-90.93M | -1,799.11% | -2,243.76% | -2,083.07% |
| 2020 | $4.04M | $-104.61M | -2,095.76% | -2,626.13% | -2,591.31% |
| 2021 | $46.72M | $-74.95M | 69.18% | -160.99% | -160.44% |
| 2022 | $9.27M | $-113.13M | -69.28% | -1,299.26% | -1,220.49% |
| 2023 | $1.33M | $-138.49M | -470.32% | -11,617.88% | -10,404.96% |